Publication | Closed Access

Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: Results from the EBMT IDWP01 trial

VaccinationTransplantationVaccine ResearchImmunologyTherapeutic VaccineEbmt Idwp01 Trial7-Valent Conjugate VaccineVaccine DesignImmunotherapyMedicineCell Transplantation